The <i>in vitro</i> and <i>in vivo</i> antiviral effects of IGF1R inhibitors against respiratory syncytial virus infection-Reference-Cited by-同舟云学术

The in vitro and in vivo antiviral effects of IGF1R inhibitors against respiratory syncytial virus infection

Published:2024-02 Issue: Volume: Page:1-12
ISSN:0739-1102
Container-title:Journal of Biomolecular Structure and Dynamics
language:en
Short-container-title:Journal of Biomolecular Structure and Dynamics

Author:

Ruan Pinglang¹²,Dai Pei²³,Mao Yu²,Tang Zhongxiang²,He Hanlin²,Wu Guojun²,Qin Ling⁴,Tan Yurong²

Affiliation:

1. Department of Dermatology, Second Xiangya Hospital, Central South University, Hunan Key Laboratory of Medical Epigenomics, Changsha, Hunan, China

2. Department of Medical Microbiology, Xiangya School of Medicine, Central South University, Changsha, Hunan, China

3. Second Department of Laboratory, Hunan Provincial People’s Hospital (The First Affifiliated Hospital of Hunan Normal University), Changsha, Hunan, China

4. Department of Respiratory Medicine, Xiangya Hospital, Central South University, Changsha, Hunan, China

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/07391102.2024.2309643

Reference33 articles.

1. PLIP 2021: expanding the scope of the protein–ligand interaction profiler to DNA and RNA

2. American Academy of Pediatrics Committee on Infectious Diseases & American Academy of Pediatrics Bronchiolitis Guidelines Committee. Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection;Pediatrics,

3. Daptomycin synergistic properties from in vitro and in vivo studies: a systematic review

4. Lung-brain axis

5. A Screen of FDA-Approved Drugs for Inhibitors of Zika Virus Infection

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunomodulatory markers and therapies for the management of infant respiratory syncytial virus infection;Expert Review of Anti-infective Therapy;2024-09-13

2. Drugs targeting CMPK2 inhibit pyroptosis to alleviate severe pneumonia caused by multiple respiratory viruses;Journal of Medical Virology;2024-05